Pharma Focus Asia

Stevanato Group Invests US$145 million in Construction of New Facility in North America

Introduction:

Stevanato Group plans to open new manufacuting facility in North America. The new facility will provide an additional supply source for its mission critical products.

Features:

The new plant will be designed with an area covering 370,000 square feet and will be used for the production of Stevanato Group’s EZ-Fill® solutions, pre-sterilized drug containment systems for pharmaceutical use.

The new state-of-the-art facility features new production lines equipped with advanced process technologies to produce EZ-Fill® syringes and vials.

Moreover, the new facility serves as a center to support customers to provide technical support as maintenance for visual inspection, assembly and packaging equipment.

The new manufacturing site will be fully opeartional by 2023. After the completion of the new facility, it is expected to create 230 new local employees for the production, engineering and maintenance, as well as other corporate support positions.

Specifications:

NameStevanato Group
TypeNew Construction
BudgetUS$145 million
Year2023
magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference